Haichen Wang

APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response.

A no-laminectomy spinal cord compression injury model in mice.

A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury.

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.

Effects of a manganese (III) porphyrin catalytic antioxidant in a mouse closed head injury model.

A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage.

Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage.

Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage.

Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway.

Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury.

COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury.

Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice.

Traumatic brain injury exacerbates neurodegenerative pathology: improvement with an apolipoprotein E-based therapeutic.

A reversible aptamer improves outcome and safety in murine models of stroke and hemorrhage.

The apoE-mimetic peptide, COG1410, improves functional recovery in a murine model of intracerebral hemorrhage.

Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents.

Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitor.

Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: A translational approach.

TT-301 inhibits microglial activation and improves outcome after central nervous system injury in adult mice.

Mn porphyrins as novel molecular magnetic resonance imaging contrast agents.

ApolipoproteinE mimetic peptides improve outcome after focal ischemia.

Lacosamide improves outcome in a murine model of traumatic brain injury.

Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage.

Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the china national stroke registry.

pH-sensitive NMDA inhibitors improve outcome in a murine model of SAH.